Preparation and biodistribution of 99mTc-IgG-HYNIC in normal rats

• Autorzy: Rajabifar S. , Akhlaghi M. , Jalilian A. R. , Bolourinovin F. , Maashkar B. , Talebimehrdar M. , Ghafouri M.
• Języki publikacji: EN

Abstrakty

EN

Human gamma globulin can be labeled by a direct or indirect method of radiotracer incorporated in a protein molecule. In this indirect method hydrazinonicotinic acid (HYNIC) is used which saves the structure and biological activity of the protein. Our goal was the efficient labeling of the human gamma globulin and evaluation of its biodistribution in different organs which can be used on experimentally induced infection causing inflammation. Immune globulin is mixed with s-hynic and IgG-hynic is developed using sidle A-lyzer and stored at –20°C which can be used at least for six months and then Sn-tricine kit is prepared which is used for 99mTc labeling. Efficiency of 99mTc-IgG-hynic labeling at pH 6.4 was very much dependent on ligand (hynic) and coligand (tricine) presence in the reaction mixture. Radiochemical purity was more than 90% in the kits prepared. Serum stability study showed no decomposition of 99mTc from the complex. The biodistribution studies showed the highest percentage ID/organ in the blood, liver and kidney, respectively. A human gamma globulin was successfully labeled through hynic to 99mTc by an indirect method with high radiochemical purity.

Słowa kluczowe

EN

99mTc; HIG; HYNIC; IgG-hynic; infection; inflammation

• Wydawca: Institute of Nuclear Chemistry and Technology
• Czasopismo: Nukleonika
• Rocznik: 2009
• Tom: Vol. 54, No. 4
• Strony: 279--284
• Opis fizyczny: Bibliogr. 55 poz., rys.

Twórcy

autor

Rajabifar S.

autor

Akhlaghi M.

autor

Jalilian A. R.

autor

Bolourinovin F.

autor

Maashkar B.

autor

Talebimehrdar M.

autor

Ghafouri M.

• Nuclear Medicine Research Group, Agricultural, Medical and Industrial Research School (AMIRS), Moazen Blvd., Rajaeeshahr, P. O. Box 31485-498, Karaj, Iran, Tel.: [phone], Fax: [phone],

Bibliografia

• 1. Abrams AJ, Juweid M, tenKate CI et al. (1990) 99mTc--human polycolonal IgG radio labeled via hydrazinonicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med 31:2022–2028
• 2. Babich JW, Dong Q, Graham W, Brazana M, Ferill K, Pike M (1997) A novel high affinity chemotactic peptides antagonist for infection imaging. J Nucl Med 38:268–272
• 3. Babich JW, Fischman AJ (1995) Effect of co ligand on the biodistribution of 99mTc-labeled hydrazinonicotinic acid derivatized chemotactic peptides. Nucl Med Biol 22:25–30
• 4. Babich JW, Graham W, Barrow SA, Fischman AJ (1995) Comparison of the infection imaging properties of a 99mTc-labeled chemotactic peptide with 111In-IgG. Nucl Med Biol 22:643–648
• 5. Babich JW, Solomon H, Pike MC et al. (1993) 99mTc- -labeled hydrazino-nicotinamide derivatized chemotactic peptide analoges of imaging focal sites of bacterial infection.J Nucl Med 34:1967–1974
• 6. Baker HC, Linsey RJ, Weisbroth SH (eds) (1980) The Laboratory Rat. Academic Press, New York 7. Becker W, Goldenberg DM, Wolf F (1994) The use of monocolonal antibodies and antibody fragments in the imaging of infectious lesions. Semin Nucl Med 24:142–153
• 8. Becker W, Saptogino A, Wolf F (1992) The singla late Tc-99m granulocyte antibody scan in inflammatory diseases. Nucl Med Commun 13:186–192
• 9. Bengrad M, Behe M, Guhlke S, Otte R, Muecke HR, Biersack HJ (2000) Detection of somatostatin receptor positive tumorsusing the new 99mTc- tricine- hunic-D phe,tyr3-octreotide: first results in patients and comparison with 111In-DTPA-Dphe1-octreotide. Eur J Nucl Med 27:628–637
• 10. Blankenberg FG, Katsikis PD, Tait JF et al. (1999) Imaging of apoptosis with 99mTc – Annexin V. J Nucl Med 40:184–191
• 11. Boerman OC, Oyen WJG, Corstens FHM (2000) Radiolabeled receptor binding peptides. A new class of radiopharmaceuticals. Semin Nucl Med 30:195–208
• 12. Brouwers AH, Oyen WJ, Boerman OC et al. (1999) Imaging experimental infection with 99mTc-labeled leukoterine-B4 (LTB4) receptor antagonist RP517. J Nucl Med 40;5:199
• 13. Chianelli M, Signore A, Fritzberg AR, Mather SJ (1997) The developement of Tc99m-labeled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune mediated diseases. Nucl Med Biol 24:579–586
• 14. Corstens FH, Oyen WJ , Becker WS (1993) Radioimmuno conjugates in the detection of infection and inflammation. Semin Nucl Med 23:148–164
• 15. Dams ETM, Oyen WJG, Boerman OC, Cleassens RAMJ, Wymenga AB, van der Meer JWM (1998) Tc-99m-labeled to human immunoglobulin G through the nicotinyl hydrazine derivative: a clinical study. J Nucl Med 39:119–124
• 16. Dams ETM, Oyen WJG, Boerman OC, Storm G, Laverman P, Koenders EB (1998) Tc 99m labeled liposomes to image experimental colitis in rabbits: comparison with Tc 99m-HMPAO-granulocytes and Tc-99m HYNIC-IgG. J Nucl Med 39:2172–2178
• 17. Datz FL, Thorne DA (1986) Effect of chronicity of infection on the sensitivity of the In-111-labeled leucocyte scan. AJR Am J Roentgenol 147:809–812
• 18. Decristoforo C, Mather SJ, Cholewinski W, Donmiller E, Ricabonna G, Moncayo R (2000) 99mTc-EDDA/HYNIC-TOC: a new 99mTc-labeled radiopharmaceutical for imaging somatostatin receptor-positive tumors: first clinical results and intra patients comparison with 111-In-labeled octreotide derivatives. Eur J Nucl Med 27:1318–1325
• 19. Fischman AJ, Babich JW, Rubin RH (1994) Infection imaging with chemotactic peptide analoges. Semin Nucl Med 24:154–168
• 20. Fischman AJ, Fucello AJ, Pellegrino-Gensey JL et al. (1992) Effect of carbohydrate modification on the localization of human polycolonal IgG at focal sites of bacterial inflammation. J Nucl Med 33:1378–1382
• 21. Fishman AJ, Rauh D, Solomon H, Babich JW, Tompkins RG, Kroon D (1993) In vivo bioactivity and biodistribution of chemotactic peptides analogs in non human
• primates. J Nucl Med 34:2130–2134
• 22. Fischman AJ, Rubin RH, White JA et al. (1990) Localization of Fc and Fab fragments of non-specific polycolonal IgG at focal sites of inflammation. J Nucl Med 31:1199–1205
• 23. Ito Y, Okuyama S, Awano T, Takahashi K, Sato T, Kanno I (1971) Diagnostic evaluation of Ga-67 scanning of lung cancer and other diseases. Radiology 101:355–362
• 24. Karczmarczyk U, Markiewicz A, Mikołajczak R et al. (2004) 99mTc human IgG radiolabeled by HYNIC. Biodistribution and scintigraphy of experimentally induced inflammatory lesions in animal model. Nucl Med Rev 7:107–112
• 25. King TP, Zhao SW, Lam T (1986) Preparation of protein conjugates via intra molecular hydrazone linkage. Biochem 25:5774–5779
• 26. Larsen SK, Abrams MJ, Higgins III JD, Solomon HF, Babich JW, Fischman AJ (1994) Technecium complexes of tricine: useful precursor for the 99mTc-labeling of hydrazino nicotin amide modified human polycolonal IgG. J Nucl Med 35:105–109
• 27. Larsen SK, Solomon HF, Caldwell G, Abrams MJ (1995) 99mTc-tricine: a useful precursor complex for the radiolabeling of hydrazinonicitinate protein conjugates. Bioconj Chem 6:635–638
• 28. Lavender JP, Lowe J, Barker JR, Burn JI, Chaudhry MA (1971) Galium-67 citrate scanning in neoplastic and inflammatory lesions. Br J Radiol 4:361–366
• 29. Liu S, Edwards DS (1999) 99mTc-labeled small peptides as diagnostic radio-pharmaceuticals. Chem Rev 99:2235–2268
• 30. Liu S, Edwards DS, Looby RJ et al. (1996) Labeling a hydrazine-nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligands. Bioconjugate Chem 7:63–67
• 31. McAfee JG, Thakur ML (1976) Survey of radioactive agents for the in vitro labeling of phagocytic leucocytes. I. Soluble agents II. Particles. J Nucl Med 17:480–492
• 32. Mairal L, Lima PD, Martin Comin J et al. (1995) Simultaneous administration of Ind. 111-human immunoglobulin and 99mTc-HMPAO labeled leucocytes in inflammatory bowel disease. Eur J Nucl Med 22:664–670
• 33. Mishra P, Singh AK, Chauhan M, Bhatnagar A, Kashyap R, Chauhan UPS (1994) A novel method for labeling human immunoglobulin-G with 99mTc suitable for inflammation scintigraphy. Nucl Med Comm 15:723–729
• 34. Moyer BR, Vallabhujusula S, Lister-James J, Bush LR, Cyr JE, Snow DA (1996) 99mTc-WBC-specific imaging agent developed from platelet factor 4 to detect infection. J Nucl Med 37:673–679
• 35. Nijhof MW, Oyen WJ, van Kampen A, Cleassens RAMJ, van der Meer JWM, Corstens FHM (1997) Evaluation of the locomotor system with Ind. 111-labeled human IgG scintigraphy. J Nucl Med 38:1300–1305
• 36. Oyen WJG, Cleassens RAMJ, Raemaekers JMM, de Pauw BE, van der Meer JWM, Corstens FHM (1992) Diagnosis infections in febrile granulocytopenic patients with Ind-111-labeled human IgG. J Clin Oncol 10:61–65
• 37. Oyen WJG, Cleassens RAMJ, van der Meer JWM, Rubin RH, Strauss HW (1992) Indium-111-labeled human non--specific immunoglobulin G: a new radiopharmaceutical for imaging infectious and inflammatory foci. Clin Infect Dis 14:1110–1118
• 38. Oyen WJG, Cleassens RAMJ, van Horn JR et al. (1990) Scintigraphic detection of bone and joint infections with indium-111 labeled non-specific polycolonal human immunoglobulin G. J Nucl Med 31:403–412
• 39. Palestro CJ (1994) The current role of galium imaging in infection. Semin Nucl Med 24:128–141
• 40. Peters AM (1994) The utility of 99mTc-HMPAO-leucocytes for imaging infection. Semin Nucl Med 24:110–127
• 41. Peters AM, Danpure HJ, Osman S (1986) Clinical experience with 99mTc hexamethylpropylene-amine oxime for labeling leucocytes and imaging inflammation. Lancet 2:946–949
• 42. Rennen HJJM, Boerman OC, Koenders EM, Oyen WJG, Corstens FHM (2000) Labeling proteins with 99mTc via hydrazinonicotinamide(HYNIC): optimization of the conjugation reaction. Nucl Med Biol 27:599–604
• 43. Rennen HJJM, Boerman OC, Oyen WJG, van der Laken CJ, Corstens FHM (2001) Specific and rapid detection of infection with Tc-99m-labeled interleukin-8. J Nucl Med 42:117–123
• 44. Rennen HJJM, Makarewicz J, Oyen WJG, Laverman P, Corstens FHM, Boerman OC (2001) The effects of molecular weight on non-specific accumulation of 99mTc--labeled proteins in inflammatory foci. Nucl Med Biol 28:401–408
• 45. Rubin RH, Young LS, Hansen WP, Nedelman M, Wilkinson R, Nelles MJ (1988) Specific and non-specific imaging of localized Fischer immunotype 1 Pseudomonas aeroginosa infection with radiolabeled monocolonal antibody. J Nucl Med 29:651–656 284 S. Rajabifar et al.
• 46. Sharma A, Sharma US (1997) Liposomes in drug delivery: progress and limitations. Int J Pharm 154:123–140
• 47. Shwartz DA, Abrams MJ, Hauser MM et al. (1991) Preparation of hydrazino modified proteins and their use for the synthesis of 99mTc-protein conjugates. Bioconj Chem 2:333–338
• 48. Signore A, Chianelli M, Moneitini L , Ronga G, Nimmon CC (1992) A radio-pharmaceutical for imaging of areas of lymphocytic infiltration, 123-I-interleukin-2 labeling procedure and animal studies. Nucl Med Commun 13:713–722
• 49. Thakur M, Marcus CS, Henneman P, Butler J, Sinow R, Diggles L (1996) Imaging inflammatory diseases with neutrophil – specific 99mTc-labeled monocolonal antibody anti SSEA-1. J Nucl Med 37:1789–1795
• 50. Tsan MF (1985) Mechanism of galium-67 accumulation in inflamatory diseases. J Nucl Med 26:128–141
• 51. van der Laken CJ, Boerman OC, Oyen WJG, van de Ven MTP, Chizzonite R, Corstens FHM (1997) Preferential localization of systemically administered radiolabeled interleukin-1 alfa in experimental inflammation in mice by binding to the type ii receptor. J Clin Invest 100:2970–2976
• 52. van der Laken CJ, Boerman OC, Oyen WJG, van de Ven MTP, Cleassens RAMJ, van der Meer JWM (1995) Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental model. Eur J Nucl Med 22:1249–1255
• 53. van der Laken CJ, Boerman OC, Oyen WJG, van de Ven MTP, van der Meer JWM, Corstens FHM (1998) Imaging of infection in rabbits with radioiodinated interleukin-1,its receptor antagonist and a chemotactic peptides: a comparative study. Euro J Nucl Med 25:347–352
• 54. van der Laken CJ, Boerman OC, Oyen WJG, van de Ven MTP, van der Meer JWM, Corstens FHM (2000) Radiolabeled interleukin-8: scintigraphic detection of infection within a few hr. J Nucl Med 41:463–469
• 55. Zoghbi S, Thakur M, Gottschalk A (1981) A selective cell labeling: a potential radioactive agent for labeling of human neutrophils. J Nucl Med 22:32